

Newborn infants, premature infants
Nursing mothers
Severe hypertension, severe coronary artery disease, severe ischemic heart disease
Within 14 days of taking monoamine oxidase (MAO) inhibitors
Narrow-angle glaucoma
Urinary retention
Peptic ulcer
During asthma attack
Treatment of lower respiratory tract conditions including asthma
Therapy may diminish mental alertness, and may cause hyperexcitability, especially in children
At doses higher than recommended dose, nervousness, dizziness, or sleeplessness may occur
Especially in infants and small children, antihistamines in overdosage may cause hallucinations, convulsions, and death
Use with caution in patients with hypertension, ischemic heart disease, and persons >60 years old
Not for administration to children who have a chronic pulmonary disease, breathing problems such as chronic bronchitis, glaucoma, or those who are taking sedatives or tranquilizers without first consulting with a doctor
Use caution in patients with hypertension, diabetes mellitus, ischemic heart disease, hyperthyroidism, increased intraocular pressure, and prostatic hypertrophy
Do not exceed recommended dosage
Discontinue use and contact healthcare professional if nervousness, dizziness, or sleeplessness occurs
Animal reproductive studies not performed with brompheniramine; also, not known if it can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity; therapy should be given to a pregnant woman only if clearly needed
Because of higher risk of intolerance of antihistamines in small infants generally, and in newborns and premature in particular, therapy is contraindicated in nursing mothers
Newborn infants, premature infants
Nursing mothers
Severe hypertension, severe coronary artery disease, severe ischemic heart disease
Within 14 days of taking monoamine oxidase (MAO) inhibitors
Narrow-angle glaucoma
Urinary retention
Peptic ulcer
During asthma attack
Treatment of lower respiratory tract conditions including asthma
Therapy may diminish mental alertness, and may cause hyperexcitability, especially in children
At doses higher than recommended dose, nervousness, dizziness, or sleeplessness may occur
Especially in infants and small children, antihistamines in overdosage may cause hallucinations, convulsions, and death
Use with caution in patients with hypertension, ischemic heart disease, and persons >60 years old
Not for administration to children who have a chronic pulmonary disease, breathing problems such as chronic bronchitis, glaucoma, or those who are taking sedatives or tranquilizers without first consulting with a doctor
Use caution in patients with hypertension, diabetes mellitus, ischemic heart disease, hyperthyroidism, increased intraocular pressure, and prostatic hypertrophy
Do not exceed recommended dosage
Discontinue use and contact healthcare professional if nervousness, dizziness, or sleeplessness occurs
Animal reproductive studies not performed with brompheniramine; also, not known if it can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity; therapy should be given to a pregnant woman only if clearly needed
Because of higher risk of intolerance of antihistamines in small infants generally, and in newborns and premature in particular, therapy is contraindicated in nursing mothers